4.3 Meeting Abstract

Quality of life and SR-fampridine in multiple sclerosis patients

Journal

MULTIPLE SCLEROSIS JOURNAL
Volume 24, Issue -, Pages 780-780

Publisher

SAGE PUBLICATIONS LTD

Keywords

-

Funding

  1. Merck-Serono
  2. Biogen-Idec
  3. Novartis
  4. Sanofi-genzyme
  5. Roche
  6. MerckSerono
  7. BiogenIdec
  8. Genzyme
  9. Tevapharmaceutical Industries Ltd.

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available